Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Alcamena Stem Cell Therapeutics LLC
Profile last edited on: 6/2/2023      CAGE: 7B1Q9      UEI: J6DAAQH7AQL8

Business Identifier: Biologic targeting Glioblastoma multiforme (GBM)
Year Founded
2014
First Award
2018
Latest Award
2020
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1450 South Rolling Road Lab 4.069
Halethorpe, MD 21227
   (650) 307-4940
   N/A
   www.alcamenabio.com
Location: Single
Congr. District: 07
County: Baltimore

Public Profile

Alcamena Stem Cell Therapeutics Inc. is developing a biologic specifically to targetGlioblastoma multiforme (GBM), a particularly aggressive cancer and the most common primary brain tumor in adults.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
2
Conversion Rate
100.00%
Phase I Dollars
$547,995
Phase II Dollars
$932,850
Total Awarded
$1,480,845

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2020 2 NIH $699,541
Project Title: Optimization and Assessment of a Biologic to Improve Functional Recovery After Peripheral Nerve Injury
2019 2 NIH $781,304
Project Title: Optimization and Assessment of a Biologic to Improve Cognitive Function After Traumatic Brain Injury

Key People / Management

  Edmund Nesti

  Leon Nesti

  Alexander Pisarchik

  Mark Verdecia

Company News

There are no news available.